Drug Shortage Report for ROSIGLITAZONE
| Report ID | 229713 |
| Drug Identification Number | 02403366 |
| Brand name | ROSIGLITAZONE |
| Common or Proper name | Rosiglitazone |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSIGLITAZONE |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 BTL |
| ATC code | A10BG |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-06-05 |
| Actual start date | |
| Estimated end date | 2024-07-02 |
| Actual end date | 2024-06-20 |
| Shortage status | Resolved |
| Updated date | 2024-06-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-06-21 | English | Compare |
| v5 | 2024-06-20 | French | Compare |
| v4 | 2024-06-20 | English | Compare |
| v3 | 2024-06-06 | English | Compare |
| v2 | 2024-06-05 | French | Compare |
| v1 | 2024-06-05 | English | Compare |
Showing 1 to 6 of 6